Evidence map›Paper›PMID 38675125›Full record

ArticlePharmaceutics2024

Antiviral Effect of Antimicrobial Peptoid TM9 and Murine Model of Respiratory Coronavirus Infection.

Maxim Lebedev, Aaron B Benjamin, Sathish Kumar, Natalia Molchanova, Jennifer S Lin, Kent J Koster, Julian L Leibowitz, Annelise E Barron, Jeffrey D Cirillo

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Maxim LebedevSchool of Medicine, Texas A&M University, Bryan, TX 77807, USA.ORCID 0000-0003-3188-1595
Aaron B BenjaminSchool of Medicine, Texas A&M University, Bryan, TX 77807, USA.ORCID 0000-0003-4387-2434
Sathish KumarSchool of Medicine, Texas A&M University, Bryan, TX 77807, USA.
Natalia MolchanovaDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Jennifer S LinDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Kent J KosterSchool of Medicine, Texas A&M University, Bryan, TX 77807, USA.
Julian L LeibowitzSchool of Medicine, Texas A&M University, Bryan, TX 77807, USA.ORCID 0000-0003-3485-3506
Annelise E BarronDepartment of Bioengineering, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-0735-6873
Jeffrey D CirilloSchool of Medicine, Texas A&M University, Bryan, TX 77807, USA.ORCID 0000-0003-3058-2702
Texas A&M University · USStanford University · USLawrence Berkeley National Laboratory · US

Funding

Role of Innate Immune Dysregulation in the Etiology of DementiaDP1AG072438 · NIA · STANFORD UNIVERSITY · PI BARRON, ANNELISE EMILY · 2020 to 2024
$5.2M
Development of a High-Throughput Microfluidics-Enabled Functional Assay for Rapidly Identifying Neutralizing AntibodiesR01AI141607 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI DE FIGUEIREDO, PAUL, HAN, ARUM · 2019 to 2023
$3.4M
Design of hetero-multivalent targeted liposome for combating intracellular Mycobacterium tuberculosisR21AI149383 · NIAID · TEXAS ENGINEERING EXPERIMENT STATION · PI CIRILLO, JEFFREY D., WU, HUNG-JEN · 2020 to 2021
$416k
Development of fluorogenic and chemiluminogenic main protease substrates for cellular and in vivo imaging of SARS-CoV-2R21EB032983 · NIBIB · TEXAS A&M UNIVERSITY · PI LIU, WENSHE RAY · 2022 to 2023
$411k
NIA NIH HHS DP1 AG072438NIH HHS 1DP1 OD029517NIH HHS AI141607NIH HHS AI149383NIH HHS EB032983
6 · The paper itself

Abstract

New antiviral agents are essential to improving treatment and control of SARS-CoV-2 infections that can lead to the disease COVID-19. Antimicrobial peptoids are sequence-specific oligo-

Indexed as

antimicrobialsMHVpeptoidSARS-CoV-2

Identifiers

PMID38675125
PMCPMC11054490
OpenAlexW4393235286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.